Table 2.
Hazard ratios for cancer incidence using the entire cohort and then restricting diabetes patients to those with < 1 year since diagnosis (mean duration 4 months). HRs are relative to age, sex and county-matched controls in each case, as per data in Table 1.
| All diabetes | Newly diagnosed (< 1 year) | ||
|---|---|---|---|
| Most common cancers | |||
| All cancer | 1.10 (1.09–1.12) | All cancer | 1.22 (1.17–1.27) |
| Breast | 1.05 (1.01–1.09) | Breast | 1.12 (1.02–1.23) |
| Lung | 1.01 (0.97–1.05) | Lung | 1.18 (1.04–1.34) |
| Prostate | 0.82 (0.80–0.83) | Prostate | 0.80 (0.70–0.90) |
| Colorectal | 1.20 (1.16–1.23) | Colorectal | 1.30 (1.18–1.43) |
| Most associated cancers | |||
| Liver | 3.31 (3.07–3.58) | Liver | 2.36 (1.74–3.20) |
| Pancreas | 2.19 (2.06–2.32) | Pancreas | 2.72 (2.28–3.25) |
| Corpus uteri | 1.78 (1.68–1.88) | Corpus uteri | 1.68 (1.44–1.96) |
| Gallbladder | 1.32 (1.13–1.54) | Gallbladder | 1.55 (1.02–2.37) |
| Kidney | 1.45 (1.36–1.54) | Kidney | 1.78 (1.45–2.19) |
| Penis | 1.56 (1.27–1.91) | Penis | 1.96 (0.77–4.99) |
| Stomach | 1.21 (1.13–1.30) | Stomach | 1.37 (1.06–1.77) |
| Bladder | 1.20 (1.15–1.25) | Bladder | 1.15 (0.96–1.37) |
| Colorectal | 1.20 (1.16–1.23) | Colorectal | 1.30 (1.18–1.43) |
Model adjusted for sex, education, income and marital status.